Abcellera Biologics (ABCL)Orbimed Advisors LLC reduced its stake -836K shares

3.34M

Shares reported · -836K vs prior quarter

0.29%

Disclosed portfolio weight

$11.5M

Reported value

Holdings as of

Jun 30, 2025

Filed

Aug 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Nov 6, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Nov 10, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 10, 2025, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Stephen Quake, D.Phil. as a new director, effective immediately.”
3. Nov 24, 2025Company filing · Form 8-K · Auditor changeChanged its auditor“On November 24, 2025, the Audit Committee of the Board of Directors (the "Audit Committee") of AbCellera Biologics Inc. (the "Company") approved the dismissal of KPMG LLP ("KPMG") as the Company's independent registered public accounting firm, effective following the completion of KPMG's audit of the Company's consolidated financial statements for the fiscal year ending December 31, 2025, and the filing of the…”

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Abcellera Biologics

For Abcellera Biologics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABCL page.

How this filing works

• SEC Form 13F

Other disclosures at Abcellera Biologics

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 4Mar 11, 2025
• SEC Form 4Mar 10, 2025
• SEC Form 4Mar 7, 2025

Everything OQRO holds on this company is on its ABCL page.